Panmure Gordon reissued their hold rating on shares of Advanced Medical Solutions Group plc (LON:AMS) in a report issued on Wednesday. The brokerage currently has a GBX 220 ($2.93) price objective on the stock.

Separately, Numis Securities Ltd restated an add rating and set a GBX 205 ($2.73) price objective on shares of Advanced Medical Solutions Group plc in a research note on Tuesday, July 5th. Five investment analysts have rated the stock with a hold rating, Advanced Medical Solutions Group plc presently has an average rating of Hold and an average target price of GBX 214.25 ($2.85).

Advanced Medical Solutions Group plc (LON:AMS) opened at 231.790176 on Wednesday. Advanced Medical Solutions Group plc has a 52 week low of GBX 150.88 and a 52 week high of GBX 239.00. The firm’s market cap is GBX 485.07 million. The stock’s 50 day moving average price is GBX 221.14 and its 200 day moving average price is GBX 196.55.

The firm also recently declared a dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, September 29th will be paid a GBX 0.30 ($0.00) dividend. The ex-dividend date is Thursday, September 29th. This represents a dividend yield of 0.13%.

About Advanced Medical Solutions Group plc

Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials.

Receive News & Ratings for Advanced Medical Solutions Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group plc and related companies with Analyst Ratings Network's FREE daily email newsletter.